An analysis of the relationship between insulin resistance and the activity of steroid C17,20-lyase and 3β-hydroxysteroid dehydrogenase in ovaries and adrenals in women with polycystic ovary syndrome

Experimental and Clinical Endocrinology and Diabetes

Volumn 108, Issue 7, 2000, Pages 455-462

  Vrbikova, J ^a   Hill, M ^a   Starka, L ^a   Vondra, K ^a   Sulcova, J ^a   Snajderova, M ^a   Cibula, D ^a   Pobisova, Z ^a   Bendlova, B ^a  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

Adrenalpolycystic ovary; C17,20 hydroxylase lyase; Insulin resistance

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; BUSERELIN; C PEPTIDE; CORTICOTROPIN; GONADORELIN; PRASTERONE; STEROID 17,20 LYASE; TETRACOSACTIDE;

ADRENAL GLAND; ADULT; AGE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN TEST; ENZYME ACTIVITY; FEMALE; GONADORELIN RELEASE; HORMONE ACTION; HORMONE RELEASE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; ORAL GLUCOSE TOLERANCE TEST; OVARY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; STEROIDOGENESIS;

17-HYDROXYPROGESTERONE; 3-HYDROXYSTEROID DEHYDROGENASES; ADRENAL GLANDS; ADULT; ANDROGENS; BLOOD GLUCOSE; C-PEPTIDE; CORTICOTROPIN; FACTOR ANALYSIS, STATISTICAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HYDROCORTISONE; INSULIN RESISTANCE; OVARY; POLYCYSTIC OVARY SYNDROME; PRASTERONE; REFERENCE VALUES; STEROID 17-ALPHA-HYDROXYLASE; SUPPORT, NON-U.S. GOV'T;

EID: 0033775858     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-8141     Document Type: Article

References (26)

1. Multifollicular ovaries: Clinical and endocrine features and response to pulsatile gonadotropine releasing hormone
2. Adrenal androgen excess in women: Lack of a role for 17-hydroxylase and 17,20-lyase dysregulation
3. Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1-24) stimulation in hyperandrogenic women
4. Reassessment of adrenal androgen secretion in women with polycystic ovary syndrome
5. The contributions of oestrogen and growth factors to increased adrenal androgen secretion in polycystic ovary syndrome
6. Adrenal hyperandrogenism in the pathophysiology of polycystic ovary syndrome
7. The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome
8. Insulin resistance and the polycystic ovary syndrome: Mechanism and implication for pathogenesis
9. A simple measure of insulin resistance
10. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion
11. Polycystic ovary syndrome: Evidence for a primary disorder of ovarian steroidogenesis
12. Hypersecretion of androstenedione by isolated theca cells from polycystic ovaries
13. Adrenal dynamic responses to physiologic and pharmacologic ACTH stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome
14. Age relationships and sex differences in serum levels of pregnenolone and 17-hydroxypregnenolone in healthy subjects
15. Differential androgen response to ACTH stimulation in polycystic ovarian syndrome: Relationship with insulin secretion
16. Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity
17. Adrenal steroidogenesis is related to insulin in hyperandrogenic women
18. Early steps in androgen biosynthesis: From cholesterol to DHEA
19. Insulin infusion amplifies 17 α hydroxycorticosteroid intermediate response to ACTH in hyperandrogenic women: Apparent relative impairment of 17, 20 lyase activity
20. The role of adrenal hyperandrogenism, insulin resistance and obesity in the pathogenesis of polycystic ovarian syndrome
21. Editorial: Evidence that idiopathic functional adrenal hyparandrogenism is caused by dysregulation of adrenal steroidogenesis and that hyperinsulinemia may be involved
22. 17hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome
23. Is 11βhydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate?
24. Der Nachweis von Dehydroepiadrosterone in menschlichen sklerocystischen ovarien
25. The treatment of insulin resistance does not improve adrenal cytochrome P 450c17α enzyme dysregulation in PCOS
26. The roles of insulin sensitivity, insulin-like growth factor I (IGF-I) and IGF-binding protein-1 and-3 in the hyperandrogenism of African-American and Caribbean Hispanic girls with premature adrenarche